ConvaTec Group Plc (CNVVY)
USD 13.29
(8.92%)
USD 13.29
(8.92%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.02 Billion USD | 1.95% |
| 2022 | 1.98 Billion USD | 0.16% |
| 2021 | 1.97 Billion USD | -5.56% |
| 2020 | 2.09 Billion USD | 2.29% |
| 2019 | 2.04 Billion USD | 0.27% |
| 2018 | 2.04 Billion USD | -10.27% |
| 2017 | 2.27 Billion USD | 0.41% |
| 2016 | 2.26 Billion USD | -43.45% |
| 2015 | 4.01 Billion USD | -3.48% |
| 2014 | 4.15 Billion USD | -6.4% |
| 2013 | 4.43 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.96 Billion USD | 0.0% |
| 2024 Q1 | 1.96 Billion USD | -2.55% |
| 2023 Q4 | 2.02 Billion USD | 0.0% |
| 2023 Q3 | 2.02 Billion USD | -4.98% |
| 2023 Q2 | 2.12 Billion USD | 0.0% |
| 2023 FY | 2.02 Billion USD | 1.95% |
| 2023 Q1 | 2.12 Billion USD | 7.3% |
| 2022 Q2 | 2.1 Billion USD | 0.0% |
| 2022 Q4 | 1.98 Billion USD | 0.0% |
| 2022 FY | 1.98 Billion USD | 0.16% |
| 2022 Q3 | 1.98 Billion USD | -5.7% |
| 2022 Q1 | 2.1 Billion USD | 6.21% |
| 2021 Q3 | 1.97 Billion USD | -2.58% |
| 2021 Q4 | 1.97 Billion USD | 0.0% |
| 2021 FY | 1.97 Billion USD | -5.56% |
| 2021 Q2 | 2.03 Billion USD | 0.0% |
| 2021 Q1 | 2.03 Billion USD | -3.06% |
| 2020 FY | 2.09 Billion USD | 2.29% |
| 2020 Q1 | 2.05 Billion USD | 0.2% |
| 2020 Q4 | 2.09 Billion USD | 0.0% |
| 2020 Q2 | 2.05 Billion USD | 0.0% |
| 2020 Q3 | 2.09 Billion USD | 2.09% |
| 2019 Q1 | 2.12 Billion USD | 4.24% |
| 2019 FY | 2.04 Billion USD | 0.27% |
| 2019 Q4 | 2.04 Billion USD | 0.0% |
| 2019 Q3 | 2.04 Billion USD | -3.8% |
| 2019 Q2 | 2.12 Billion USD | 0.0% |
| 2018 Q3 | 2.04 Billion USD | -8.85% |
| 2018 FY | 2.04 Billion USD | -10.27% |
| 2018 Q2 | 2.24 Billion USD | 0.0% |
| 2018 Q1 | 2.24 Billion USD | -1.56% |
| 2018 Q4 | 2.04 Billion USD | 0.0% |
| 2017 FY | 2.27 Billion USD | 0.41% |
| 2017 Q1 | 2.29 Billion USD | 1.03% |
| 2017 Q2 | 2.29 Billion USD | 0.0% |
| 2017 Q3 | 2.27 Billion USD | -0.61% |
| 2017 Q4 | 2.27 Billion USD | 0.0% |
| 2016 Q3 | 2.26 Billion USD | -62.14% |
| 2016 FY | 2.26 Billion USD | -43.45% |
| 2016 Q4 | 2.26 Billion USD | 0.0% |
| 2016 Q2 | 5.98 Billion USD | -0.69% |
| 2016 Q1 | 6.03 Billion USD | 50.4% |
| 2015 Q3 | 5.98 Billion USD | 0.76% |
| 2015 Q4 | 4.01 Billion USD | -33.05% |
| 2015 FY | 4.01 Billion USD | -3.48% |
| 2015 Q2 | 5.94 Billion USD | 3.64% |
| 2015 Q1 | 5.73 Billion USD | -6.54% |
| 2014 Q4 | 6.13 Billion USD | -3.25% |
| 2014 Q1 | 6.74 Billion USD | 0.82% |
| 2014 Q2 | 6.65 Billion USD | -1.43% |
| 2014 FY | 4.15 Billion USD | -6.4% |
| 2014 Q3 | 6.34 Billion USD | -4.65% |
| 2013 Q2 | 6.33 Billion USD | 0.83% |
| 2013 Q3 | 6.6 Billion USD | 4.27% |
| 2013 Q1 | 6.28 Billion USD | 0.0% |
| 2013 FY | 4.43 Billion USD | 0.0% |
| 2013 Q4 | 6.69 Billion USD | 1.34% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -85905.709% |
| Ansell Limited | 1.32 Billion USD | -51.966% |
| Ansell Limited | 1.33 Billion USD | -51.681% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -1499.68% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -214176.929% |
| Psykey, Inc. | 2.47 Million USD | -81588.944% |
| ConvaTec Group Plc | 2.01 Billion USD | -0.141% |
| Encision Inc. | 1.98 Million USD | -101766.562% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -66369.79% |
| Innovative MedTech Inc. | 6.13 Million USD | -32842.978% |
| LifePoint, Inc. | 2.45 Million USD | -82249.667% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -19750.702% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -59341.176% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -66373.2% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -260227.773% |
| SmileDirectClub, Inc. | 982.26 Million USD | -105.75% |
| Sector 10, Inc. | 9.84 Million USD | -20427.294% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -49.074% |
| SheerVision, Inc. | 1.43 Million USD | -141090.147% |
| United Health Products, Inc. | 1.99 Million USD | -101007.176% |
| Vasamed, Inc. | 1 Million USD | -200934.517% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -53080.222% |
| Yubo International Biotech Limited | 2.91 Million USD | -69256.648% |